We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

LHSW:NASDAQLianhe Sowell International Group Ltd Analysis

Data as of 2026-07-06 - not real-time

$6.51

Latest Price

8/10Risk

Risk Level: High

Executive Summary

The stock has surged from a previous close of $1.80 to $6.51, placing it near the upper end of its recent range but still well below the 52‑week high of $50.24. RSI is at 79, indicating overbought conditions, while the MACD histogram is positive, suggesting short‑term bullish momentum despite a broader bearish trend direction. The 20‑day SMA ($2.31) sits far below the current price, and the price is trading near the identified resistance of $7.74 with support around $1.47.
Fundamentally, revenue has jumped 57% year‑over‑year, yet operating margins are negative (‑3.7%) and cash on hand ($90,608) is minuscule compared with debt of $3.5 million, yielding a debt‑to‑equity ratio above 20. The trailing PE of 15.5 is well under the industry average of 36.9, hinting at relative undervaluation, but the lack of dividend and thin free cash flow raise sustainability concerns.
Recent material news includes a supply agreement for AI‑powered automotive painting robots in Southeast Asia and a 1‑for‑16 share consolidation, both of which could provide a short‑term catalyst but do not resolve the underlying balance‑sheet weakness.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 7/10

Key Factors

  • RSI in overbought territory
  • Extreme price volatility (413% 30‑day)
  • Recent share consolidation may distort price

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • Strong revenue growth (57%)
  • Negative operating margin and high debt load
  • Potential upside from AI robot supply agreement

Long Term

> 3 years
Cautious
Model confidence: 4/10

Key Factors

  • Sustained cash‑flow weakness and zero free cash flow
  • High beta (2.83) and historic drawdown of ~97%
  • Regulatory and geopolitical exposure in China

Key Metrics & Analysis

Financial Health

Revenue Growth56.90%
Profit Margin2.48%
P/E Ratio15.5
ROE9.22%
ROA1.92%
Debt/Equity20.22
P/B Ratio1.2
Industry P/E36.9

Technical Analysis

TrendBearish
RSI79.3
Support$1.47
Resistance$7.74
MA 20$2.31
MA 50$3.00
MA 200$12.71
MACDBullish
VolumeIncreasing
Fear & Greed Index92.59

Valuation

GradeUndervalued
TypeBlend

Risk Assessment

Beta2.83
Volatility413.09%
Sector RiskHigh
Reg. RiskHigh
Geo RiskHigh
Currency RiskHigh
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.